Finanzielle Vergleiche Lonza Group AG

Aktien

928619

CH0013841017

LONN

Biotechnologie

Markt geschlossen - Swiss Exchange 17:31:24 17.02.2026 % 5 Tage Veränd. 1. Jan.
536.20 CHF +1.71% Intraday Chart für Lonza Group AG +3.96% -0.30%
Hauptkonkurrenten
Umsatz (Y-1) Nettogewinn (Y-1) EBIT-Marge (Y-1) ROE (Y-1) ROA (Y-1) Verschuldungsgrad (Y-1)
7.25 Mrd. 9.67%17.9%6.77%3.48%1.5x
3.81 Mrd. -16.92%-14.91%-18.77%-11%4.06x
2.41 Mrd. 11.88%13.83%2.46%2.14%1.28x
15.4 Mrd. 8.91%20.12%33.53%5.12%3.33x
7.2 Mrd. 5.84%14.63%7.8%3.73%1.93x
846 Mio. -31.67%-18.92% - - 1.57x
705 Mio. -64.4%-67.38%-93.12%-15.15%2.26x
2.53 Mrd. 17.83%20.93%70.23%22.13%-0.89x
1.98 Mrd. 4.23%28.66%13.31%8.32%0.34x
12.94 Mio. -1’409.6%-1’383.2%-148.95% - 0.4x
1.22 Mrd. 6.02%31.45%15.37%11.65%0.43x
693 Mio. -107.63%-20.47% - -25.37%0.13x
8.55 Mio. -2’137.48%-2’340.29%-70.98%-64.03%1.96x
509 Mio. -13.19%-41.67%-31.26%-21.6%-0.14x
4.05 Mrd. 0.25%19.9%15.1%6.78%2.05x
1.68 Mrd. 14.61%17.14%13.7%7.12%1.33x
905 Mio. 6.14%7.92%1.94%1.39%0.27x
8.28 Mrd. 9.56%19.29%12.39%6.87%1.66x
Durchschnitt 3.31 Mrd. -204.77% -204.17% -10.65% -3.65% 1.31x
Gewichteter Durchschnitt nach Marktkapitalisierung 4.57 Mrd. -118.02% -114.76% -5.16% -1.99% 1.74x
Biotechnologie und medizinische Forschung - Andere